May 2016 $64 M No. 5 $50 to $250 million 20
TransMedics, Inc.: Raise no. 5, May 2016 × Investors in this round 20 investors had bought by the notice of Jul 12, 2016: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $64 M of $64 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Stephen R. Gordon · Executive Officer Waleed H. Hassanein · Executive Officer, Director David R. Abrams · Director Dmitry R. Kobyzev · Director Edward R. Basile · Director Edwin M. Kania, Jr. · Director James R. Gilbert · Director James R. Tobin · Director Travis R. Rhodes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Gordon, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 12, 2016. Read the notice at the SEC .
equity SEC May 2015 $20 M No. 4 $10 to $50 million 11
TransMedics, Inc.: Raise no. 4, May 2015 × Investors in this round 11 investors had bought by the notice of Jun 4, 2015: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Stephen Lee Gordon · Executive Officer Waleed H. Hassanein · Executive Officer, Director David Lee Abrams · Director Earl M. Collier, Jr. · Director Edwin M. Kania, Jr. · Director James R. Tobin · Director Joseph S. Lacob · Director Kenneth M. Bate · Director Tony Lee White · Director Travis Lee Rhodes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Gordon, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 4, 2015. Read the notice at the SEC .
equity SEC Nov 2012 $36 M No. 3 $10 to $50 million 15
TransMedics, Inc.: Raise no. 3, Nov 2012 × Investors in this round 15 investors had bought by the notice of Nov 21, 2012: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $36 M of $36 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $425,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Domenic Lee Micale · Executive Officer Waleed H. Hassanein · Executive Officer, Director David Lee Abram · Director Earl M. Collier · Director Edwin M. Kania, Jr. · Director James M. Tobin · Director Joseph M. Lacob · Director Kenneth M. Bate · Director Tony Lee White · Director Travis Lee Rhodes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Piper Jaffray & Co. (CRD 665) · broker-dealer Piper Jaffray & Co. (CRD 665) · Minneapolis, Minnesota Sold in MA Signed by Domenic Micale, Vice President of Finance. Source: SEC Form D, newest notice filed Nov 21, 2012. Read the notice at the SEC .
equity, options SEC Aug 2011 $6 M No. 2 $2 to $10 million 9
TransMedics, Inc.: Raise no. 2, Aug 2011 × Investors in this round 9 investors had bought by the notice of Aug 15, 2011: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $23 M offered; $17 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Domenic M. Micale · Executive Officer Waleed H. Hassanein · Executive Officer, Director Earl M. Collier · Director Edwin M. Kania, Jr. · Director James M. Tobin · Director Joseph M. Lacob · Director Kenneth M. Bate · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Domenic Micale, Vice President of Finance. Source: SEC Form D, newest notice filed Aug 15, 2011. Read the notice at the SEC .
equity SEC Feb 2010 $35 M No. 1 $10 to $50 million 26
TransMedics, Inc.: Raise no. 1, Feb 2010 × Investors in this round 26 investors had bought by the notice of Mar 1, 2010: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $35 M of $35 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Waleed H. Hassanein · Executive Officer, Director Adam M. Grosser · Director Edwin M. Kania, Jr. · Director Joseph M. Lacob · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total amount sold includes approximately $9 million worth of equity issued from converted debt.”Signed by Waleed H. Hassanein, President and CEO. Source: SEC Form D, newest notice filed Mar 1, 2010. Read the notice at the SEC .
equity SEC